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Abstract
E-cadherin complexes with the actin cytoskeleton via cytoplasmic catenins and maintains
the functional characteristics and integrity of the epithelia in normal epithelial tissues. Lost
expression of E-cadherin disrupts this complex resulting in loss of cell polarity, epithelial
denudation and increased epithelial permeability in a variety of tissues. Decreased expres-
sion of E-cadherin has also been observed in invasive and metastatic human tumors. In this
study, we investigated the effect of E-cadherin loss in prostatic epithelium using newly
developed genetically engineered mouse models. Deletion of E-cadherin in prostatic luminal
epithelial cells with modified probasin promoter driven Cre (PB-Cre4) induced the develop-
ment of mouse prostatic intraepithelial neoplasia (PIN). An increase in levels of cytoplasmic
and nuclear β-catenin appeared in E-cadherin deleted atypical cells within PIN lesions.
Using various experimental approaches, we further demonstrated that the knockdown of E-
cadherin expression elevated free cytoplasmic and nuclear β-catenin and enhanced andro-
gen-induced transcription and cell growth. Intriguingly, pathological changes representing
prostatic epithelial cell denudation and increased apoptosis accompanied the above PIN
lesions. The essential role of E-cadherin in maintaining prostatic epithelial integrity and orga-
nization was further demonstrated using organoid culture approaches. To directly assess
the role of loss of E-cadherin in prostate tumor progression, we generated a new mouse
model with bigenic Cdh1 and Pten deletion in prostate epithelium. Early onset, aggressive
tumor phenotypes presented in the compound mice. Strikingly, goblet cell metaplasia was
observed, intermixed within prostatic tumor lesions of the compound mice. This study pro-
vides multiple lines of novel evidence demonstrating a comprehensive role of E-cadherin in
maintaining epithelial integrity during the course of prostate oncogenic transformation,
tumor initiation and progression.
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008451 October 28, 2019 1 / 26
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Olson A, Le V, Aldahl J, Yu E-J, Hooker E,
He Y, et al. (2019) The comprehensive role of E-
cadherin in maintaining prostatic epithelial integrity
during oncogenic transformation and tumor
progression. PLoS Genet 15(10): e1008451.
https://doi.org/10.1371/journal.pgen.1008451
Editor: Gregory S. Barsh, Stanford University
School of Medicine, UNITED STATES
Received: June 10, 2019
Accepted: October 1, 2019
Published: October 28, 2019
Copyright: © 2019 Olson et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: This work was supported by the NIH
grants R01CA070297, R01CA151623,
R01CA166894, R21CA190021, and
R01DK104941. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Author summary
The biological significance of E-cadherin in maintaining prostatic epithelial integrity and
related molecular mechanisms are still unclear. In this study, using mouse genetic tools,
we directly address this important and unresolved question. Conditional deletion of E-
cadherin in mouse prostatic epithelia resulted in prostatic intraepithelial neoplasia (PIN)
development but no prostatic tumor formation. Both in vivo and in vitro data showed that
loss of E-cadherin modulates the cellular localization of β-catenin, elevates its cytoplasmic
and nuclear levels, and enhances its activity in transcription and cell proliferation. Intrigu-
ingly, in addition to PIN lesions, increased epithelial denudation and cell apoptosis also
appeared within PIN lesions. This implicates that although lost E-cadherin is sufficient to
introduce oncogenic transformation in prostatic epithelia, it also induces cell apoptosis
and disrupts epithelial structure, preventing atypical PIN cells from progressing to tumor
cells. Simultaneous deletion of Pten, a tumor suppressor, and E-cadherin in prostatic epi-
thelia resulted in early onset, invasive prostatic tumors with admixture of goblet cells.
These results demonstrate a critical role of E-cadherin in promoting prostatic tumor
transdifferentiation and progression. This study further elucidates the dynamic role of E-
cadherin in maintaining prostatic epithelial integrity during tumor initiation and
progression.
Introduction
Maintaining the integrity of cell-cell contacts is essential in the development of multicellular
organisms. Cadherins are key regulators in this biological event and play a critical role in mor-
phogenic processes during development [1–3]. E-cadherin, coded by Cdh1, is the founder
member of the cadherin superfamily and complexes with actin cytoskeleton and cytoplasmic
catenin molecules in order to maintain the functional characteristics and integrity of epithelia
[4,5]. Disruption of the E-cadherin mediated complex, due primarily to lost or decreased
expression of E-cadherin, resulted in epithelial abnormalities and severe developmental defects
in a variety of tissues and organs [6–8]. Conditional deletion of the Cdh1 gene in mouse mam-
mary glands disrupts terminal differentiation and results in massive cell death in mutant mam-
mary glands [9]. Similarly, temporal deletion of E-cadherin in Nkx3.1 expressing cells in
prostatic epithelium induces apoptotic cell death via anoikis, which subsequently promotes
vertical divisions from prostatic basal to luminal cells and increases luminal cell growth and
expansion [10].
Aberrant expression and mutations in the CDH1 gene have been observed in many human
epithelial tumors [11]. Loss or reduction of E-cadherin expression appears in many advanced,
poorly differentiated, and invasive human tumors, suggesting that reducing cell-cell contacts
mediated by E-cadherin promotes tumor progression and metastasis [12,13]. It has been
shown that aberrant E-cadherin expression in tumor cells dysregulates the cytoplasmic pools
of β-catenin and enhance its activity in transcription [14]. Cellular levels of β-catenin are
tightly regulated in normal cells and aberrant increased β-catenin expression has been closely
corroborated in oncogenic transformation during the course of tumor initiation [15]. Muta-
tions in both β-catenin and its destruction complex components can increase nuclear β-cate-
nin levels, have been observed in many tumors and are directly associated with human
tumorigenesis [15,16]. However, mutations in β-catenin, APC, and other components of the
destruction complex appear very rarely in prostate cancer cells [17–19], suggesting that other
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regulatory mechanisms underlie the activation of Wnt/β-catenin signaling in promoting pros-
tate tumorigenesis.
In this study, we assessed the critical role of E-cadherin in prostate development and
tumorigenesis using mouse genetic tools. Conditional deletion of E-cadherin in mouse pros-
tatic epithelial cells induces the development of mouse prostatic intraepithelial neoplasia
(PIN). An increase in cytoplasmic and nuclear β-catenin, and its activity in transcription and
cell proliferation were observed in E-cadherin deleted cells in both in vivo and in vitro experi-
ments. However, no prostatic tumors were observed in the E-cadherin mutant mice. Intrigu-
ingly, in addition to oncogenic transformation and PIN formation, loss of cell-cell adhesion
and prostatic epithelial structure as well as elevated epithelial denudation and cell apoptosis
appeared in prostate tissues of the mutant mice. Observations of these distinct cellular events
in prostatic epithelia suggest that although lost E-cadherin is sufficient to introduce oncogenic
transformation, it also induces cell apoptosis and disrupts epithelial structure and cell-cell con-
tacts which in turn prevents atypical PIN cells from progressing to tumor cells. Using the
newly generated Pten and E-cadherin compound knockout mice, we further investigated the
effect of E-cadherin loss in prostate tumor progression. Early onset and invasive prostatic
tumors with an admixture of goblet cells were observed in the prostate of compound mice.
Our findings provide fresh insight into the comprehensive role of E-cadherin in maintaining
epithelial integrity during prostate tumor initiation and progression.
Results
Conditional deletion of E-cadherin expression in prostatic luminal cells
E-cadherin plays an essential role in maintaining epithelial integrity, and loss or reduction of
E-cadherin expression has been linked to abnormal development and tumorigenesis
[3,9,12,20]. To directly assess the effect of E-cadherin loss in prostate epithelia, we generated a
conditional Cdh1 deletion mouse line, Cdh1L/L:PB-Cre4, in which conditional deletion of the
Cdh1 allele is regulated through Cre expression by a modified probasin promoter, ARR2PB, in
prostatic luminal epithelia (Fig 1A). To confirm PB-Cre4 mediated recombination, genomic
DNA samples were isolated from the four different prostate lobes (anterior, dorsal, lateral and
ventral) individually as well as from the testes, liver, kidney, bladder and tail of a Cdh1L/L:
PB-Cre4 mouse (Fig 1B). Although an approximately 980 bp PCR fragment representing
floxed Cdh1 alleles appeared in all of the above mouse tissues, an approximately 350 bp PCR
fragment, corresponding to the deletion of exons 6 through 10 of Cdh1 alleles, was only
observed in prostatic lobes (Fig 1B), suggesting specific deletion of E-cadherin in prostate tis-
sues. Reduction of E-cadherin protein expression was observed in prostate tissue samples of
Cdh1L/L:PB-Cre4 mice by western blotting (Lane 2 in Fig 1C). The reduction of E-cadherin
expression was further assessed by immunohistochemistry (IHC) in both Cdh1L/L:PB-Cre4
and control mice. Typical prostatic glandular structure appeared in tissue samples isolated
from Cdh1L/L mice (Fig 1D and 1D’) with uniform cellular membrane staining of E-cadherin
in luminal epithelial cells (blue arrows, Fig 1E and 1E’). However, pathologic changes similar
to prostatic hyperplasia and prostatic intraepithelial neoplasia, PIN, presented in prostate tis-
sues of Cdh1L/L:PB-Cre4 mice (Fig 1F and 1F’). Intriguingly, loss of E-cadherin expression
appeared in a portion of prostatic epithelia, mainly within PIN lesions. These E-cadherin nega-
tive cells appeared to cluster between the basement membrane and a layer of epithelium with
intact E-cadherin, reminiscent of pagetoid spread (pink arrows, Fig 1G’). The above observa-
tion of partial E-cadherin deletion in prostate epithelia is new and intriguing. The pagetoid dis-
tribution of E-cadherin negative cells is very similar histologically to reports of E-cadherin
negative lobular carcinoma in situ (LCIS) of the breast [21,22]. To confirm that loss of E-
A comprehensive role of E-cadherin loss in prostatic epithelia
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cadherin expression is indeed a direct result of Cre mediated recombination, we generated a
new mouse strain, R26mTmG/+:Cdh1L/L:PB-Cre4, in which the change in expression from mem-
brane-targeted tandem dimer tomato (mT) to membrane-targeted green fluorescence protein
(mGPF) and deletion of Cdh1 occur simultaneously through Cre mediated recombination (S1
Fig 1. Generation of Probasin driven prostate specific deletion of E-cadherin in mice. A. A scheme was shown of
the targeted Cdh1 allele undergoing Probasin driven Cre mediated recombination. B. Recombination PCR with DNA
isolated from Cdh1L/L:PB-Cre4 anterior prostate (AP), lateral prostate (LP), dorsal prostate (DP), ventral prostate (VP)
and other tissues as indicated. Band sizes correspond to the DNA ladder in the left lane. C. Western blot results from
protein lysates isolated from prostate tissues of Cdh1L/L: PB-Cre4 and Cdh1L/L control mice. D-G’. Representative H&E
& E-cadherin IHC staining of prostate tissue sections from Cdh1L/L:PB-Cre4 and Cdh1L/L mice. Blue arrows indicate E-
cadherin positive epithelium (E’). Pink arrows indicate E-cadherin negative regions with dotted lines marking the
border between E-cadherin negative cells and surrounding E-cadherin positive epithelium (G’). H1-I4. Representative
images of Co-IF staining of mouse prostate sections displaying overlay of E-cadherin and mGFP (yellow arrows, H4)
in R26mTmG/+; PB-Cre4 control mice. Lost/reduced E-cadherin staining is observed in mGFP+ (yellow arrows, I4) cells
of R26mTmG/+:Cdh1L/L:PB-Cre4 mice. Cells without mGFP expression retain E-cad positivity in R26mTmG/+:Cdh1L/L:
PB-Cre4 mice (pink arrows, I4). Scale bars, located in the bottom left corner of images, are sized as indicated.
https://doi.org/10.1371/journal.pgen.1008451.g001
A comprehensive role of E-cadherin loss in prostatic epithelia
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Fig.). Co-immunofluorescence staining (Co-IF) showed clear overlay of E-cadherin and
mGFP proteins in prostate epithelial cells of R26mTmG/+:PB-Cre4 control mice (yellow arrows,
Fig 1H3-4). In contrast, epithelial cells with either GFP or E-cadherin staining presented in
prostate samples of R26mTmG/+:Cdh1L/L:PB-Cre4 mice (yellow or pink arrows respectively, Fig
1I3-4), indicating a mosaic recombination occurring in mouse prostatic epithelia. These data
not only demonstrate the deletion of E-cadherin in prostatic epithelium through Probasin
driven Cre expression but also elucidate the mosaic nature of this recombination event in the
prostate of Cdh1L/L:PB-Cre4 mice.
Loss of E-cadherin expression in prostatic luminal cells induces prostatic
intraepithelial neoplasia formation
The Cdh1L/L:PB-Cre4 offspring were born at the expected Mendelian ratios and appeared nor-
mal with no obvious differences from their Cdh1L/L controls and wild-type littermates at birth.
Per the recommendations of the Mouse Models of Human Cancers Consortium Prostate
Pathology Committee [23], we assessed Cdh1L/L:PB-Cre4 mice from birth and identified path-
ological lesions resembling low grade PIN starting at about 6 weeks. Prostate tissues isolated
from two-month-old Cdh1L/L:PB-Cre4 mice showed clear PIN lesions in both the DP and LP
regions (Fig 2C1-4). In addition to PIN lesions, an increase in detached epithelial cells also pre-
sented in lumen of prostatic glands in the above tissues (blue arrows Fig 2C1-4). At 6 months
of age, Cdh1L/L:PB-Cre4 mice showed similar PIN lesions present in all four prostate lobes but
with fewer detached cells (Fig 2D1-4). No abnormalities were observed in sex and age matched
Cdh1L/L control mice (Fig 2A1-4 and 2B1-4). These observations demonstrate that the deletion
of E-cadherin induces prostatic epithelial cell oncogenic transformation and PIN formation.
However, continuing examining old aged Cdh1L/L:PB-Cre4 mice, showed no or slow progres-
sion of PIN lesions with age and no prostate tumors were observed in mice up to 12 months of
age (Table 1). These data demonstrate conditional deletion of E-cadherin in prostatic luminal
epithelia is insufficient to promote PIN to progress to prostate cancer, suggesting that other
cellular events may co-occur and play a tumor suppressive role during the course of E-cad-
herin loss in prostatic epithelia.
Using immunohistochemical (IHC) approaches, we further evaluated the cellular properties
of atypical cells within the above PIN lesions. A cluster of E-cadherin negative cells was present
under a layer of E-cad expressing epithelial cells, consistent with pagetoid distribution as
described earlier (pink arrows, Fig 2F1, also see Fig 1G’). Most atypical cells also showed posi-
tive staining for AR, and CK8, a prostatic luminal cell marker (Fig 2F2 and 2F3). Intriguingly,
an increase in CK5 positive cells was observed within the above PIN lesions. CK5 and CK8
positive staining was observed in the same areas in adjacent tissue sections (pink arrows, Fig
2F3 and 2F4), suggesting that those cells express both CK5 and CK8, possessing intermediate
cellular properties. In this study, we also observed the anoikis of E-cadherin negative cells that
were spilled into the lumen from regions where, at the epithelial apical surface, the layer of E-
cadherin positive cells was disrupted (blue arrows, Fig 2F1). Using Co-IF approaches, we
examined if prostatic epithelial cell anoikis can induce luminal cell replenishment through
increased differentiation from basal cells and subsequent cell proliferation [10]. A significant
increase in intermediate epithelial cells with both CK5 and CK8 positive staining (pink arrows,
Fig 2G4) was observed within PIN lesions in comparison with the adjacent epithelia. The
majority of these intermediate cells appeared negative for E-cadherin staining (Fig 2H1-4) but
showed high levels of positive staining for PCNA (Fig 2I1-4), suggesting their newly generated
and proliferative nature. These observations demonstrate that luminal epithelial denudation
and subsequent basal to luminal epithelial replenishment co-occur during the course of PIN
A comprehensive role of E-cadherin loss in prostatic epithelia
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Fig 2. Prostate specific E-cadherin knockout results in PIN with Pagetoid Features. A1-D4. Representative H&E
images of prostate sections from mice of the indicated genotypes and ages. Blue arrows indicate cells observed
sloughing off into the lumen (C1-C4). E1-F4. Representative images of IHC staining for the indicated proteins in
prostate tissue sections of Cdh1L/L:PB-Cre4 & Cdh1L/L mice. Pink arrows indicate clusters of E-cadherin null cells (F1).
A comprehensive role of E-cadherin loss in prostatic epithelia
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008451 October 28, 2019 6 / 26
lesion development in E-cadherin deletion epithelia. These data also implicate that while dele-
tion of E-cadherin increases proliferative properties of atypical cells, it also impairs their ability
to maintain cell-cell contacts resulting in detachment from the epithelium and restricting pro-
gression to prostatic tumor lesions.
Deletion of E-cadherin increases the cytoplasmic and nuclear localization
as well as the transcriptional activity of β-catenin in prostate cancer cells
Previous studies have shown that mutations in β-catenin, APC, and other components of the
destruction complex appear very rarely in prostate cancer cells [17–19], implicating other reg-
ulatory mechanisms for activating Wnt/β-catenin signaling in promoting prostate tumorigen-
esis. Disruption of E-cadherin-involved protein complexes with the actin cytoskeleton and
catenins has been frequently observed in many human tumor samples including prostate can-
cers [5,24,25,26]. A regulatory role of E-cadherin in cytoplasmic and nuclear β-catenin has
been implicated in prostate cancer cells [27,28]. In this study, we assessed the effect of E-cad-
herin loss on β-catenin expression and cellular localization using IHC approaches with adja-
cent tissue sections prepared from Cdh1L/L:PB-Cre4 and Cdh1L/L mice. Increased cytoplasmic
and nuclear staining of β-catenin was observed in E-cadherin negative atypical cells within
PIN lesions of Cdh1L/L:PB-Cre4 mice (Pink arrows, Fig 3B2-3). Those cells also showed
increased staining for Cyclin D1, a transcriptional downstream target of β-catenin, and Ki67
(Fig 3B4-5). In contrast, typical cellular membrane staining for E-cadherin and β-catenin and
no or very weak staining for CyclinD1 and Ki67 presented in prostatic epithelial cells in tissue
samples of Cdh1L/L controls (Fig 3A2-5). Using Co-IF approaches, we further examined the
loss of E-cadherin in correspondence to the expression of cytoplasmic and nuclear β-catenin
within PIN lesions of Cdh1L/L:PB-Cre4 mice. As shown in Fig 3D1, increased cytoplasmic and
nuclear staining of β-catenin appeared in a cluster of E-cadherin null epithelial cells whereas
the adjacent E-cadherin positive cells retained typical membrane staining for β-catenin. In
adjacent tissues sections, positive staining for Myc, Cyclin D1, and PCNA also appeared in E-
cadherin negative cells (blue arrows, Fig 3D2-4). In prostate tissues of Cdh1L/L control mice,
The interface between E-cadherin positive and E-cadherin negative cells is shown with red dashed lines (F1). PIN
lesions are indicated with pink arrows F3 and F4. G1-I4. Representative images of CoIF staining for various antibodies
as indicated. CK5 and CK8 positive intermediate cells are indicated with pink arrows (G4). Scale bars, located in the
bottom left corner of images, are sized as indicated.
https://doi.org/10.1371/journal.pgen.1008451.g002
Table 1. Pathological abnormalities in the prostates of Cdh1L/L:PB-Cre4 mice.
Prostate Lobe < 2 Months 2–4 Months 4–12 Months
Anterior Prostate 2 of 4 Normal
2 of 4 LGPIN�
1 of 5 Normal
3 of 5 Hyperplasia
1 of 5 LGPIN
1 of 5 Normal
2 of 5 Hyperplasia
2 of 5 LGPIN
Dorsal Prostate 1 of 4 Normal
3 of 4 LGPIN
2 of 5 Hyperplasia
3 of 5 LGPIN
1 of 5 Hyperplasia
4 of 5 LGPIN
Lateral Prostate 1 of 4 Normal
1 of 4 Hyperplasia
2 of 4 LGPIN
2 of 5 Hyperplasia
3 of 5 LGPIN
1 of 5 Hyperplasia
4 of 5 LGPIN
Ventral Prostate 1 of 4 Normal
3 of 4 Hyperplasia
1 of 5 Normal
2 of 5 Hyperplasia
2 of 5 LGPIN
3 of 5 Normal
1 of 5 Hyperplasia
1 of 5 LGPIN
�LGPIN: Low grade prostatic intraepithelial neoplasia
https://doi.org/10.1371/journal.pgen.1008451.t001
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Fig 3. Loss of E-cadherin induces Wnt/β-catenin signaling activation in prostate cancer cells. A1-B5. Representative H&E and IHC images of adjacent
prostate tissue sections from Cdh1L/L and Cdh1L/L:PB-Cre4 mice stained with antibodies as indicated. E-cadherin negative PIN cells (pink arrows, B2) display
increased cytoplasmic and nuclear staining for β-cat (pink arrows, B3). C1-D4. Representative images of Co-IF staining of adjacent prostate tissue sections
from Cdh1L/L:PB-Cre4 and Cdh1L/L mice. Cells with detectable expression for Wnt-signaling proteins (β-cat, Myc, CyclinD1) and proliferation marker PCNA
are indicated with green arrows (D1-D4). E. Western blot results for LNCap & LAPC4 cell lines treated with either control or one of three E-cadherin ShRNA
lentiviruses. F-G. Relative PSA-luciferase activity observed in LNCaP and LAPC4 cells treated with control and E-cadherin ShRNA1 with increasing
concentrations of DHT in the medium. H. Western blot results from LNCaP cells separated into cytoplasmic/membrane & nuclear fractions following
treatment with control or E-cadherin ShRNA1 for 18 and 24 hrs. I. Relative luciferase activity in LNCaP cells treated with E-cadherin ShRNA1 in addition to
indicated concentrations of β-cat and AR ShRNAs. All conditions were performed both in the presence and absence of DHT. J. MTS assay results representing
the number of LNCaP cells for 8 days with control or E-cad ShRNA1 treatments as indicated. K. Images of two wells from each group as indicated after a
12-day colony formation assay. Images were taken following fixation and staining with crystal violet. Scale bars, located in the bottom left corner of images, are
sized as indicated.
https://doi.org/10.1371/journal.pgen.1008451.g003
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there was overlaid staining on the cellular membrane of both E-cadherin and β-catenin in
prostatic epithelial cells and negative staining for Myc, Cyclin D1, and PCNA (Fig 3C1-4).
These data demonstrate that loss of E-cadherin expression increases the level of cytoplasmic
and nuclear β-catenin which further enhances the transcriptional activity of β-catenin in
inducing Cyclin D1 and Myc expression in the prostate of Cdh1L/L:PB-Cre4 mice.
Observation of increasing expression in β-catenin downstream target genes, Myc and
Cyclin D1 in atypical cells bearing E-cadherin loss within PIN lesions in Cdh1L/L:PB-Cre4 mice
suggests a promotional role of β-catenin in oncogenic transformation. It has also been shown
that β-catenin is a co-activator of the AR and enhances AR mediated transcription [29,30]. To
test if loss of E-cadherin can modulate AR mediated transcription via altered β-catenin levels
in prostate cancer cells, we specifically knocked down endogenous E-cadherin expression
using small hair-pin RNA interference approaches in human prostate cancer cell lines. As
shown in Fig 3E, the knockdown of E-cadherin expression was observed with two shRNA len-
tiviruses for E-cadherin on both LNCaP and LAPC4 cell lines. To examine the effect of E-cad-
herin knockdown on AR mediated transcriptional activity, we transfected luciferase reporter
plasmids driven by the human prostate specific antigen, PSA, promoter into the above cells. A
significant increase in androgen-dependent induction of AR-mediated transcription was
observed in samples infected with E-cadherin shRNA lentiviruses (black bars vs. white bars,
Fig 3F and 3G). Increased levels of both cytoplasmic and nuclear β-catenin appeared in cells
infected with E-cadherin shRNA lentiviruses in comparison to ones infected with control
viruses (Fig 3H). Despite increased AR-mediated transcription, AR protein levels remained
consistent between mice with and without knockdown of E-cadherin demonstrating that the
increase in transcription is the result of β-catenin induced co-activation (Fig 3H). In support
of these observations, reducing either β-catenin or AR expression using specific shRNA lenti-
viruses significantly attenuated androgen-induced AR-mediated transcriptional activity onset
by E-cadherin knockdown in cells, providing evidence of a direct role of β-catenin in enhanc-
ing AR transcriptional activity in E-cadherin null prostate cancer cells (Fig 3I). To investigate
the role of E-cadherin loss in prostate cancer cell growth, LNCaP cells infected with either E-
cadherin shRNA or control lentiviruses were examined by the MTS assay. The numbers of
cells infected with E-cadherin shRNA lentiviruses were significantly higher after 6- and 8-day
culture in comparison to controls (Fig 3J). The growth promoting effect of E-cadherin knock-
down in prostate cancer cells was further examined using colony formation assay. Approxi-
mately 500 LNCaP cells that were infected with either E-cadherin shRNA or control
lentiviruses were seeded, cultured for 12 days, and then fixed and stained with crystal violet.
There were more and larger colonies in E-cadherin shRNA infected LNCaP cells than controls
(Fig 3K). These data further demonstrate a direct link between deleting E-cadherin expression
and elevating cytoplasmic and nuclear β-catenin levels in prostate cancer cells. Given the role
of β-catenin as an AR co-activator [31,32], our data further showed that elevated β-catenin
promotes AR-mediated transcription and cell growth in E-cadherin deleted prostate cancer
cells, elucidating the molecular mechanisms for loss or reduction of E-cadherin in inducing
oncogenic transformation and PIN development.
Deletion of E-cadherin in prostatic epithelium impairs prostatic
morphogenesis and prostatic gland formation in organoid culture
To further assess the effect of E-cadherin deletion in the fate of prostatic epithelial cells, we
generated organoid cultures using prostatic cells isolated from R26mTmG/+:Cdh1L/L:PB-Cre4
and R26mTmG/+:Cdh1L/L mice. After 5 days of culture, organoids derived from prostatic epithe-
lial cells of R26mTmG/+:Cdh1L/L mice showed normal glandular structure (Fig 4A1), which were
A comprehensive role of E-cadherin loss in prostatic epithelia
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008451 October 28, 2019 9 / 26
fully composed of mT positive cells (Fig 4A2). Histologically typical prostate glands composed
of E-cadherin positive epithelial cells presented (Fig 4A3 and 4A4). In contrast, the organoids
Fig 4. Loss of E-cadherin impedes prostatic epithelial integrity in organoid cultures. A1-B4. Representative images
comparing organoids established from primary prostate cells from R26mTmG/+:Cdh1L/L:PB-Cre4 mice and R26mTmG/+:
Cdh1L/L littermate controls. Bright-field images depict organoid morphology observed in each genotype (A1, B1). 3D
z-stack images of organoids expressing mTmG reporter fluorescence controlled by Cre recombination (A2 and B2).
Green arrows indicate mG positive cells and white arrows indicate mT positive cells due to mosaic recombination
events in R26mTmG/+:Cdh1L/L:PB-Cre4 mice (B2). Representative images of H&E staining and E-cadherin IHC staining
in control and E-cadherin KO organoids (A3-A4, B3-B4). Arrows indicate unstructured E-cadherin negative cells
separating from organoids (B3-B4). C1-C4. Representative fluorescence images of CoIF staining for E-cadherin and
GFP in organoids. White arrows indicate mGFP- E-cadherin+ cells while green arrows indicate mGFP+ E-cadherin-
cells (C4). D1-E3’ Representative H&E and fluorescence images of prostate tissue sections from R26mTmG/+:Cdh1L/L:
PB-Cre4 and R26mTmG/+:Cdh1L/L mice. White arrows indicate E-cadherin negative cells and TUNEL positive cells (E2’
and E3’ respectively). Nuclei were stained with DAPI. Scale bars, located in the bottom left corner of images, are sized
as indicated.
https://doi.org/10.1371/journal.pgen.1008451.g004
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derived from the prostatic epithelial cells of R26mTmG/+:Cdh1L/L:PB-Cre4 mice showed abnor-
mal, unorganized structure (Fig 4B1). Both mT and mGFP expressing cells were observed in
the above organoids, suggesting the occurrence of a mosaic recombination (Fig 4B2). Discohe-
sive cellular structures and lost cell-cell contact appeared only in mGFP expressing cells of
organoids (green arrows, Fig 4B2). In contrast, organoids comprised of mT positive cells
maintained normal smooth-edged organoid structure (white arrows, Fig 4B2). IHC analysis
further showed that E-cadherin negative cells formed unstructured cell clusters (arrows, Fig
4B3-4) in contrast with the adjacent E-cadherin positive glandular structures. Using co-IF
approaches, we demonstrated that clustered E-cadherin negative and mGFP positive cells were
loosely connected and failed to form normal prostate glands (green arrows, Fig 4C4). How-
ever, E-cadherin positive but mGFP negative cells formed typical glandular structures in the
organoids (white arrows Fig 4C4). These data suggest an irreplaceable role of E-cadherin in
prostatic epithelial development, morphogenesis and cell survival despite the concurrent onco-
genic capacity introduced by loss of E-cadherin.
To extend our results from prostate organoid cultures, we assessed the effect of E-cadherin
deletion in prostatic epithelium using prostate tissue of Cdh1L/L:PB-Cre4 mice. Clusters of
atypical cells appeared loose and unstructured in the lumen of abnormal prostatic glands pos-
sessing PIN changes (Fig 4E1). Immunostaining showed that these cells were negatively
stained for E-cadherin and positive with TUNEL (Fig 4E2-3’), demonstrating increased apo-
ptosis in these E-cadherin deletion cells. In contrast, prostatic glands from Cdh1L/L control
mice maintained normal, single layered epithelia possessing uniform E-cadherin positive cells
with very rare TUNEL staining (Fig 4D1-3’). These results are consistent with our previous
observations in prostatic organoid culture and implicate a comprehensive role of E-cadherin
deletion in inducing cell apoptosis, which co-occurs with oncogenic transformation simulta-
neously in the prostate of Cdh1L/L:PB-Cre4 mice.
Increased injury repair signaling pathways in prostate epithelium with E-
cadherin deletion
In search of the molecular basis for the biological role of E-cadherin deletion in the mouse
prostate, we analyzed RNA-sequencing data to examine the global transcriptome profiles of
Cdh1L/L:PB-Cre4 versus Cdh1L/L control mice. Based on 450 upregulated and 182 downregu-
lated DEGs as previously reported (GEO accession: GSE115204) [33], we used DAVID soft-
ware analysis of Gene Ontology (GO) biological processes and KEGG pathways to identify
pathways up and down regulated in prostatic epithelial cells from Cdh1L/L:PB-Cre4 mice versus
littermate controls. Interestingly, pathways related to immune response and inflammation
appeared significantly enriched in prostate tissues of Cdh1L/L:PB-Cre4 mice (Fig 5A). In addi-
tion, signaling pathways related to oncogenic transformation and tumorigenesis were also
enriched in the above analysis, such as the PI3k-Akt signaling pathway. GSEA analyses of
these DEGs showed a similar enrichment of cell signaling pathways related to apoptosis,
inflammatory responses, and cell adhesion molecules (Fig 5B–5E). These data suggest that the
co-existing oncogenic transformation and cell apoptosis in PIN lesions with E-cadherin nega-
tive epithelia induce similar cellular responses as injury including increased apoptosis, inflam-
mation and immune responses.
Simultaneous deletion of E-cadherin and Pten in prostate epithelium
induces earlier onset and more aggressive prostatic carcinomas
Loss or reduction of E-cadherin has been shown to occur frequently in many advanced and
invasive human tumors, and directly contributes to tumor progression [12,13]. Aberrant PI3K
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signaling alterations have been observed in advanced and metastatic prostate cancers [34,35].
Recent studies further suggest that loss of E-cadherin and PI3K activation co-exist in human
tumors and play a collaborative role in tumor progression [36]. To directly assess the role of E-
cadherin deletion in tumor progression, we generated Cdh1L/L:PtenL/L:PB-Cre4 compound
mice (Fig 6A), in which deletion of the tumor suppressor Pten and Cdh1 simultaneously occur
in mouse prostatic epithelium. We observed accelerated prostate cancer development and pro-
gression as well as early onset of inflammation in compound mice in comparison to PtenL/L:
Fig 5. RNA sequencing results indicate increased inflammatory/immune signaling along with increased
PI3K-AKT signaling & apoptosis in E-cadherin KO prostate epithelial cells. A. DAVID v6.8 results identifying
biological processes as being up-regulated in epithelial cells isolated from Cdh1L/L:PB-Cre4 mice vs. Cdh1L/L control
mice. Gene count indicates the number of genes from each gene set that were upregulated in E-cadherin KO mice
compared to controls.–log10 P-value indicates the statistical significance of up-regulation for each pathway. B-E.
Gene Set Enrichment Analysis (GSEA) results depicting Hallmark and KEGG pathways significantly up-regulated in
Cdh1L/L:PB-Cre4 mice versus Cdh1L/L control mice. Genes were pre-ranked by p-value for this analysis. All pathways
displayed had p-value<0.05.
https://doi.org/10.1371/journal.pgen.1008451.g005
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PB-Cre4 mice (Fig 6B and 6C1-4’ versus 6D1-2’). In addition to histological lesions reflecting
earlier prostatic tumor invasion (Fig 6C1-1’), various pathologies were also shown in tumor
samples of the compound mice, including aberrant differentiation (Fig 6C2-2’), transepithelial
leukocyte migration (Fig 6C3-3’), and pools of extracellular mucin spilling into the stromal
compartment (Fig 6C4-4’). IHC analysis showed E-cadherin negative tumor cells (red arrows,
Fig 6E2) surrounded by E-cadherin expressing cells within tumor lesions of the compound
mice. Expression of the AR and CK8 appeared in both E-cadherin positive and negative tumor
cells (Fig 6E3 and 6E5). However, CK5 staining presented predominately in E-cadherin nega-
tive tumor cells (Fig 6E6). Cytoplasmic staining of β-catenin was also observed in E-cadherin
negative cells in contrast to clear membrane staining observed in E-cadherin positive cells (Fig
Fig 6. E-cadherin-Pten bigenic knockout results in increased invasion, inflammation & goblet cell metaplasia in
the prostate. A. Gene construct of the targeted Pten floxed allele in addition to the previously described Cdh1 targeted
allele undergoing recombination in the presence of PB-Cre4. B. Table summarizing the pathological phenotypes
observed in Cdh1L/L:PtenL/L:PB-Cre4 vs PtenL/L:PB-Cre4 control mice by age. C1-C4’ Representative images of key
pathological features observed in 5–10 month old Cdh1L/L:PtenL/L:PB-Cre4 mice. Pathological features include invasive
adenocarcinoma with goblet cell metaplasia indicated by arrows (C1’). Red arrows indicate areas with goblet cell
metaplasia (C1’and C2’). D1-D2’ Representative images of typical PIN features observed in 5–10 month old PtenL/L:
PB-Cre4 control mice. E1-F6. Representative images of H&E and IHC staining using the indicated antibodies from
adjacent prostate tissue sections from Cdh1L/L:PtenL/L:PB-Cre4 and PtenL/L:PB-Cre4 mice. Red arrows indicate E-
cadherin negative cells (E2). Scale bars, located in the bottom left corner of images, are sized as indicated.
https://doi.org/10.1371/journal.pgen.1008451.g006
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6E4 and 6F4). In PtenL/L:PB-Cre4 mice, most prostatic tumor cells were stained positively for
E-cadherin, AR, and CK8 (Fig 6F2, 6F3 and 6F5, respectively) while CK5 positive cells were
mainly observed lining the basement membrane areas (Fig 6F6). Taken together, the develop-
ment of an early onset and aggressive tumor phenotype in Cdh1L/L:PtenL/L:PB-Cre4 compound
mice in comparison with PtenL/L:PB-Cre4 mice demonstrates a promotional role of E-cadherin
deletion in prostate tumor formation and progression.
Development of invasive adenocarcinoma with mucinous features in the
prostate of Cdh1L/L:PtenL/L:PB-Cre4 mice
As age progressed, Cdh1L/L:PtenL/L:PB-Cre4 compound mice further developed more aggres-
sive tumor phenotypes with a variety of pathological changes. Importantly, we observed a dis-
tinct population of cells resembling goblet cells admixed with different prostatic tumor lesions.
As shown in Fig 7A to 7C, goblet cell metaplasia presented in lesions with adenocarcinoma in
situ, invasive adenocarcinoma, and invasive mucinous carcinoma. While prostatic adenocarci-
noma lesions presented both with and without goblet cell metaplasia (Fig 7A1 and 7A2 respec-
tively), increased numbers of goblet cells appeared in early invasive tumor lesions (Fig 7B1-1’)
and in more extensively invasive lesions with pools of extracellular mucin (Fig 7C1-2’), sug-
gesting an association between the presence of goblet cells and tumor invasiveness and aggres-
siveness. High magnification visualization of these tumor lesions showed typical goblet cell
morphology (arrows, Fig 7D1’). These goblet cells feature large mucin filled vacuoles displac-
ing the nucleus to the cell periphery [37] and were observed in 12 of 13 (~92%) Cdh1L/L:PtenL/
L:PB-Cre4 mice over 5 months of age (Fig 7F). To evaluate the status of neutral mucinous com-
ponents within the goblet cells, we performed Periodic acid-Schiff (PAS) staining. Clear posi-
tive staining of PAS appeared in goblet cells (red arrows, Fig 7D2’). Interestingly, staining for
E-cadherin still appeared in most prostatic goblet cells (Fig 7D3-3’). Weak AR staining was
shown in most goblet cells and the majority of goblet cells were stained positive for CK8 as
well. Interestingly, goblet cells and the majority of the surrounding epithelium stained negative
for CK5 indicating the loss of the basal layer of the epithelium in these regions (Fig 7D4-6’). In
more severe cases, invasive carcinomas with prominent goblet and signet ring cells were
observed as shown in Fig 7E1-6’. These invasive lesions contained extracellular mucin along
with intracellular mucin vacuoles (Fig 7E1-E2’). In additional, PAS negative signet ring cells
(SRCs) were observed within these lesions (arrows, Fig 7E1 and 7E2). Furthermore, these
highly aggressive lesions stained completely negative for E-cadherin while maintaining posi-
tive AR and CK8 staining (Fig 7E3, 7E4 and 7E6). Only sparse CK5 staining was observed in
mucinous carcinoma lesions (Fig 7E5–7E5’). Taken together, we demonstrate that simulta-
neous deletion of E-cadherin and Pten in mouse prostate epithelium promotes tumor cell
transdifferentiation and invasiveness, and produces more aggressive tumor phenotypes with
goblet and signet ring cell infiltration.
Discussion
In this study, we evaluated the biological role of E-cadherin in the mouse prostate using newly
generated genetically engineered mouse models. As detailed above, Cdh1L/L:PB-Cre4 mice
developed pathological lesions that are very similar to PIN as early as 6 weeks of age but failed
to develop invasive prostatic tumor lesions. Intriguingly, in addition to the above PIN lesions,
an increase in epithelial denudation and apoptotic cells also presented in prostatic epithelium
of Cdh1L/L:PB-Cre4 mice. These data suggest that loss of E-cadherin in prostatic epithelial cells
not only leads to oncogenic transformation and growth but also disrupts epithelial organiza-
tion and induces cell apoptosis and tissue damage. With these two distinct fates, E-cadherin
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deletion cells appear insufficient to progress and form prostate tumors as we observed in
Cdh1L/L:PB-Cre4 mice. These new lines of scientific evidence implicate a dynamic role of E-
cadherin in prostatic epithelium during the course of prostate cell oncogenic transformation
and growth. Although the molecular mechanisms for PIN failing to progress to prostate
tumors in this mouse model need to be further investigated, increased cell apoptosis and tissue
damage in E-cadherin deletion cells suggest that additional abnormalities and mutations are
required for E-cadherin negative atypical cells to survive, progress and form prostate tumors.
Since E-cadherin complexes with the actin cytoskeleton via cytoplasmic catenins to main-
tain the functional characteristics of epithelia [38], it has been shown that loss of E-cadherin
resulted in increased cytoplasmic and nuclear levels of β-catenin in tumor cells [14]. In addi-
tion, lost or reduced expression of E-cadherin has been shown to disrupt this complex in
advanced and poorly differentiated prostate cancers [25]. In this study, we performed a series
of experiments to examine whether the cadherin-bound pool of β-catenin can be released and
participate in the canonical Wnt-signaling pathway and act as a co-activator of the AR [29,30].
We showed that knockdown of E-cadherin expression elevated free cytoplasmic and nuclear
β-catenin levels, and increased androgen-induced transcription activity in prostate cancer
cells. Intriguingly, knockdown of either β-catenin or AR expression in the above experiments
significantly attenuated androgen-induced transcriptional activity. Using both cell prolifera-
tion and colony formation assays, we further demonstrated a promotional role of E-cadherin
knockdown in enhancing cell growth and colony formation in the above prostate cancer cells.
These data implicate that loss of E-cadherin increases the level of cytoplasmic and nuclear β-
catenin and enhances the activity of the AR-mediated transcription and cell growth. In accor-
dance with the above results, we also observed elevated expression of cytoplasmic and nuclear
β-catenin in E-cadherin deleted atypical cells within PIN lesions in Cdh1L/L:PB-Cre4 mice.
Moreover, an increase in both Cyclin D1 and Myc expression, the downstream targets of β-
catenin, also appeared in the above E-cadherin deleted cells. Since mutations in β-catenin,
APC, and other components of the destruction complex appear very rarely in prostate cancer
cells [17–19], our data from both in vitro and in vivo experimental approaches provide scien-
tific evidence to elucidate a novel molecular mechanism underlying E-cadherin in regulating
β-catenin cellular localization, and activity in promoting oncogenic transformation and cell
growth in prostate cancer cells.
In this study, in addition to PIN development, increased cell apoptosis was also observed in
prostatic epithelium of Cdh1L/L:PB-Cre4 mice. The anoikis of prostatic luminal epithelial cells
appeared both in prostate tissues and organoids derived from prostatic epithelial cells of
Cdh1L/L:PB-Cre4 mice. An increase in prostatic intermediate cells also presented in the above
tissue and organoid samples, implicating prostatic luminal cell replenishment by increasing
basal to luminal epithelial cell differentiation. The above pathological changes appeared much
more obviously in younger Cdh1L/L:PB-Cre4 mice at less than three months of age. Observa-
tion of co-existing PIN lesions and cell anoikis in the prostate of the E-cadherin deletion mice
is novel and interesting. The above two distinct cellular events have actually been reported in
two separate studies previously [10] [33]. Temporal deletion of E-cadherin using Nkx3.1
driven Cre-ER showed apoptotic cell death mainly via anoikis and increased vertical divisions
Fig 7. Goblet cell metaplasia is associated with increased invasion and tumor aggression in E-cadherin-Pten bigenic knockout mouse prostates.
A-C2’. H&E images of prostate tissue sections from Cdh1L/L:Pten L/L:PB-Cre4 mice between 15 & 20 months of age. D1-D6’. Representative images of
goblet cell metaplasia using various stains as indicated. Arrows denote PAS positive goblet cells (D1’ and D2’). E1-E6’. Representative images
characterizing the expression pattern observed in adenocarcinoma cells with goblet cell differentiation. Arrows denote signet ring cells observed amongst
invasive E-cadherin negative epithelial cells (E1’ and E2’). F. Table summarizing pathological observations in Cdh1L/L:Pten L/L:PB-Cre4 mice according to
age. Scale bars, located in the bottom left corner of images, are sized as indicated.
https://doi.org/10.1371/journal.pgen.1008451.g007
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from prostatic basal to luminal cells, but no PIN formation [10]. These results are consistent
with our observations and implicate the critical role of E-cadherin in maintaining epithelial
integrity in the prostate. In a similar study, the development of PIN and prostate cancer was
observed in the mouse line with conditional deletion of E-cadherin using Probasin-Cre [33],
but interestingly, no anoikis in prostate tissues was observed. Although the reasons causing the
above discrepancy between our study and the previous report are unclear, the pagetoid distri-
bution of E-cadherin deleted cells within PIN lesions in our current mouse model provide sci-
entific evidence to demonstrate the nature of these cells being physically restrained within the
epithelium in order to survive. The presence of E-cadherin positive cells within PIN lesions of
the current Cdh1L/L:PB-Cre4 mice further implicate luminal cell replenishment and mosaic
recombination occurring during the course of PIN and cellular apoptosis events. In this study,
using R26mTmG/+:Cdh1L/L:PB-Cre4 mouse strain, we also confirmed mosaic deletion of Cdh1
in prostatic epithelial cells. These multiple lines of evidence demonstrate an essential role of E-
cadherin in maintaining prostate epithelial integrity for epithelial differentiation and growth.
Loss of E-cadherin expression has been observed in advanced and metastatic prostate can-
cer [25]. To assess the biological role of E-cadherin loss in prostate cancer progression, we gen-
erated the Cdh1L/L:PtenL/L:PB-Cre4 compound mouse model, in which both E-cadherin and
Pten deletion co-occur in mouse prostate epithelium. Given the biological significance of PI3K
signaling pathway alterations in prostate cancer, this new bigenic deletion mouse model can
also address a collaborative role of Pten and E-cadherin loss in prostate cancer initiation and
progression. An accelerated PIN and prostate tumor development was observed in Cdh1L/L:
PtenL/L:PB-Cre4 compound mice in comparison to PtenL/L:PB-Cre4 only mice. Pathological
analysis of Cdh1L/L:PtenL/L:PB-Cre4 compound mice showed a variety of pathologic changes,
reflecting more aggressive tumor phenotypes. In addition to invasive prostatic adenocarci-
noma lesions observed in PtenL/L:PB-Cre4 mice, Cdh1L/L:PtenL/L:PB-Cre4 compound mice also
showed poorly differentiated prostatic invasive mucinous carcinomas. The presence of infil-
trating myeloid-derived suppressor cells (MDSCs) has been reported in prostatic tumors of
PtenL/L:PB-Cre4 mice [39]. Interestingly, we observed an apparent increase in the number of
MDSCs in tumor lesions of Cdh1L/L:PtenL/L:PB-Cre4 compound mice compared to PtenL/L:
PB-Cre4 mice (S2A1-2 Fig and S2B1-2 Fig). An increase in cell numbers with positive staining
for MDSC markers, Cd11b and Gr-1, was also revealed in prostatic tumor lesions of Cdh1L/L:
PtenL/L:PB-Cre4 compound mice compared to PtenL/L:PB-Cre4 mice (S2A3-4 Fig and S2B3-4
Fig). In support of these observations, increased expression of iNOS and Arg1, two genes com-
monly expressed by MDSCs, were also observed in prostatic tumor tissues of the Cdh1L/L:
PtenL/L:PB-Cre4 compound mice in comparison with either PtenL/L:PB-Cre4 or Cdh1L/L:
PB-Cre4 mice (S2C Fig). Moreover, elevated activation of PI3K/AKT pathways also appeared
in tumor samples of the compound mice in comparison with those of PtenL/L:PB-Cre4 or
Cdh1L/L:PB-Cre4 mice. Furthermore, increased expression of anti-apoptotic regulator, Bcl-2,
was also observed in prostate tissue samples of Cdh1L/L:PtenL/L:PB-Cre4 mice compared to
those of Cdh1L/L:PB-Cre4 or PtenL/L:PB-Cre4 mice (S2H Fig). These data provide more scien-
tific insight into the molecular basis for the promotional role of E-cadherin loss in Pten-defi-
cient prostatic tumor progression. The above mouse models will provide the useful tools for
more in-depth mechanistic investigation in the future.
Most notably from this study, we identified goblet cell metaplasia within tumor lesions of
Cdh1L/L:PtenL/L:PB-Cre4 compound mice. Goblet cell related tumor lesions are relatively rare
and have not been frequently observed in prostate mouse models. The goblet cells feature large
mucin filled vacuoles displacing the nucleus to the cell periphery [37]. The presence of pros-
tatic goblet cell metaplasia in this mouse model was accompanied by inflammatory lesions,
cystic prostate gland formation, transepithelial leukocyte migration, and extracellular pools of
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mucin. Interestingly, most goblet cells identified in prostatic tumor lesions appeared to retain
E-cadherin expression, suggesting that goblet cells do not originate from E-cadherin deletion
cells but rather arise through other mechanisms during the course of tumor progression. It
will be significant and interesting to further assess the potential effect of inflammatory
responses in goblet cell metaplasia development using the current mouse models.
Taken together, results presented in this study implicate a critical role of E-cadherin in
prostate morphogenesis and tumorigenesis. Our data show that loss of E-cadherin expression
not only induces oncogenic transformation and PIN development through elevating cyto-
plasmic and nuclear β-catenin expression and activity but also disrupts normal epithelial struc-
ture and cell-cell contacts resulting in apoptosis and inflammatory responses. In combination
with Pten deletion in the mouse prostate, loss of E-cadherin results in an early onset and more
aggressive prostate tumor development. Importantly, more aggressive pathological changes
with prostatic goblet cell metaplasia are featured in the prostate tumor lesions in the com-
pound mice. Further investigation using these new mouse models should provide fresh insight
into the effect of E-cadherin loss in prostate development, morphogenesis, and tumorigenesis.
Material and methods
Ethics statement
All experimental procedure and care of animals in this study were carried out according to the
Institutional Animal Care and Use Committee (IACUC) at Beckman Research Institute at
City of Hope, and approved by the IACUC. Euthanasia was performed by CO2 inhalation fol-
lowed by cervical dislocation.
Mouse mating and genotyping
The mice used in this study were all from a C57BL/6 background. The Cdh1 floxed mice
(Cdh1L/L) were kindly provided by Dr. Rolf Kemler [9]. The PB-Cre4 mice were obtained from
the NCI mouse repository (strain #: 01XF5). Rosa26mTmG/+ (R26mTmG/+) reporter mice were
kindly provided by Dr. Liqun Luo [40]. The Pten floxed mice (PtenL/L) were kindly provided
by Dr. Hong Wu [41]. Experimental mice were generated by intercrossing Cdh1L/L females
with Cdh1L/L:PB-Cre4 males. Similar mating procedures were used to generate R26mTmG/+:
Cdh1L/L:PB-Cre4 and R26mTmG/+:Cdh1L/L mice. The Cdh1 and Pten bigenic knockout mice
were generated by mating Cdh1L/L:PtenL/L females with Cdh1L/L:PtenL/L:PB-Cre4 males. Geno-
typing was performed as previously described [42–44]. DNA samples collected from different
prostatic lobes and tissues of Cdh1L/L:PB-Cre4 and Cdh1L/L mice, including testis, liver, kidney,
bladder and tail were used. For the detection of the recombined Cdh1 allele, the forward
primer (5’- GAATTCTGAACATCATTATCAGTATTTA- 3’) and reverse primer (5’-TGACA
CATGCCTTTACTTTAGT- 3’) were used with the following conditions: 94˚C for 2 min, 94˚C
for 30’, 52˚C for 45’, 72˚C for 45’. Detection of the Cdh1 targeted allele used forward primer,
5’-CTTATACCGCTCGAGAGCCGG-3’ and reverse primer, 5’-GTGTCCCTCCAAATCC
GATA-3’. Detection of the Pten allele used the forward primer, 5’-TCCCAGAGTTCATACC
AGGA-3’ with the reverse primer, 5’-AATCTGTGCATGAAGGGAAC-3’. For the R26mTmG/+
alleles the forward primer, 5’-TCAATGGGCGGGGGTCGTT-3’ was used with reverse prim-
ers, 5’-CTCTGCTGCCTCCTGGCTTCT-3’ and 5’-CGAGGCGGATCACAAGCAATA-3’.
Lastly, detection of the PB-Cre4 allele used forward primer, 5’-GATCCTGGCAATTTCGGC
TAT-3’ and reverse primer, 5’-GCAGGAAGCTACTCTGCACCTTG-3’. Genomic PCR con-
ditions for targeted alleles were amplified at 95˚C for 3 min, then 95˚C for 45 sec, 58˚C for 40
sec, and 72˚C for 60 sec for 35 cycles, then 72˚C for 5 min.
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Pathological analyses
Mouse tissue samples were fixed in 10% neutral-buffered formalin and processed in paraffin
or processed to OCT following cryo-protection in 30% sucrose in 1X PBS pH 7.3 at 4˚C over-
night as previously described [45,46]. Following embedding in paraffin or OCT, tissue blocks
were cut to 4 μm serial sections and used for hematoxylin-eosin (H&E) staining for further
pathological analyses [46]. Pathological analyses were performed in accordance with the guide-
lines recommended by The Mouse Models of Human Cancers Consortium Prostate Pathology
Committee in 2013 [23].
Immunohistochemistry (IHC), Immunofluorescence (IF), PAS and PAS/D,
mTmG, and TUNEL assays
IHC was performed following rehydration of tissue sections through a decreasing ethanol gra-
dient. Antigen retrieval was performed using a microwave to boil the slides in 0.01M citrate
buffer (pH 6.0) followed by 15 min in 0.3% H2O2 in methanol. Tissue sections then underwent
blocking for 1 hr at room temperature in 5% goat serum in 1X PBS (pH 7.3) and incubated
with primary antibodies in 1% goat serum in PBS overnight at 4˚C. Tissues sections were
washed with PBS and then incubated with biotinylated secondary antibodies for 1 hr at room
temperature in 1% goat serum in PBS. Then, slides were incubated with Streptavidin ligated to
horse radish peroxidase (Strep-HRP) (SA-5004, Vector Laboratories, 1:500 dilution) for 30
min and developed with 3,3’-diaminobenzidine (DAB) kit (SK-4100, Vector Laboratories).
Tissue sections were counterstained in 5% Harris Hematoxylin and dehydrated through an
increasing ethanol gradient. Coverslips were mounted using Permount Medium (SP15-500,
Fisher Scientific) as described previously [47].
Immunofluorescence staining was performed using the similar procedures as described
above for IHC, but excluding the use of H2O2 in methanol. Slides were developed with fluores-
cent-conjugated secondary antibodies and then mounted with coverslips using Vectashield
Mounting Medium with DAPI (H-1200, Vector Laboratories). The mTmG assay was per-
formed as previously described [48]. Briefly, sections from OCT embedded tissues were
washed with PBS, pH 7.3, and then developed with Vectashield Mounting Medium with DAPI
(H-1200, Vector Laboratories). For the TUNEL assay, Click-iT Plus TUNEL Assay Kit
(C10617, Invitrogen) was used according to the manufacturer protocol (MAN0010877). Anti-
bodies used for both IHC and IF are listed (S1 Table).
PAS staining was performed as described earlier [49]. Briefly, PAS/D sections were treated
with 1% diastase (AHDIA50, American MasterTech) in H2O for 30 min and 0.5% periodic
acid (19840–0050, Acros) for 5 min at room temperature. After rinsing with H2O, Schiff’s
reagent (26312-1A, Electron Microscopy Sciences) was added for 30 min at room temperature.
Slides were rinsed in lukewarm water and counterstained with hematoxylin. Slides were dehy-
drated through an increasing ethanol gradient and coverslips were mounted using Permount
Medium (SP15-500, Fisher Scientific).
Microscope image acquisition
Images of immunohistochemistry and H&E staining were taken using an Axio Lab A1 micro-
scope using 5x, 10x, 20x and 40x Zeiss A-Plan objectives. A Canon EOS 1000D camera and
axiovision software (Carl Zeiss, Oberkochen, Germany) were used to capture images. Fluores-
cence imaging was performed using a Nikon ECLIPSE E800 Epi-Fluorescence Microscope
using 20x and 40x Nikon Plan Fluor objectives with a QImaging RETIGA EXi camera and
using QCapture software (QImaging). Three-dimensional z-stack imaging was performed
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using a Zeiss Inverted LSM700 Microscope with Zen 2012 imaging software for acquisition
and analysis.
Organoid culture
Primary prostate tissue was collected from R26mTmG/+:Cdh1L/L:PB-Cre4 and R26mTmG/+:Cdh1L/
L littermates at 6 weeks of age. Mouse prostate tissues were minced and then dissociated to sin-
gle cells by digestion using collagenase/hyaluronidase (C/H) & TrypLE (12605–028, Gibco).
Digested cells were resuspended in Dulbecco’s Modified Eagle’s Medium (DMEM)/Ham’s F-
12 50/50 Mix (DMEM/F12) plus 10% FBS, penicillin-streptomycin, Y-27632 dihydrochloride
and dihydrotestosterone (DHT) and approximately 30,000 cells per well were plated with
Matrigel (BD Biosciences, #356231) into 24-well plates. Cells were cultured in DMEM/F12
with B7, N-acetylcysteine, EGF, Noggin, R-spondin1, A83-01, Y-27632 and DHT, as previ-
ously described [50], for 3 days before changing to fresh medium for the last two days. Follow-
ing the 5-day culture, organoids were collected, washed with PBS and fixed in 10% neutral-
buffered formalin before being embedded in Histogel (HS-4000-012, ThermoFisher) and
undergoing paraffin embedding for histological analysis. For full mount analysis, organoids,
following fixation, were suspended in 30% sucrose.
Cell cultures, lentivirus and adenovirus production, and Transient
transfections
The human embryonic kidney cell line, HEK293, was maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 5% fetal calf serum (FCS) (HyClone, Denver,
CO). Human prostate cancer cell lines, LNCaP and LAPC4, were maintained as described pre-
viously [32]. Transient transfections were carried out using a Lipofectamine 2000 kit (Invitro-
gen, Carlsbad, CA). Approximately 1.5x104 cells were seeded into a 48-well plate 16 hrs before
transfection. Approximately 300 ng of total plasmid DNA and 0.5 μl of Lipofectamine-2000
per well were used in the transfection as previously described [51]. To generate shRNA lentivi-
ruses, pLenti-shRNA vectors, pCMV-dR8.91, and pMD2.G-VSVG plasmids were co-trans-
fected into HEK293T cells at a ratio of 3:2:1 using a Lipofectamine kit as described previously
[52,53]. The media were replaced at 6 hrs post-transfection and then collected 36 to 40 hrs
later. The viral supernatant was centrifuged briefly to remove cellular debris and stored at
-80˚C. Lentivirus infection was carried out in the presence of 6 mg/ml Polybrene [54,55].
Preparation of the cytosolic fraction and nuclear extracts
LNCaP cells were cultured for making nuclear extracts and cytosolic fractions as described in
the previous report [56]. Nuclear extracts were prepared essentially according to the method
of Dignam et al with minor modifications [57]. Briefly, the cells were washed with PBS and
mechanically disrupted by scraping into homogenization buffer A (10mM Hepes pH 7.9,
10mM KCl, 1.5mM MgCl2, 0.5mM DTT, and 0.5mM PMSF) and incubated on ice for 10 min.
Cells were further disrupted by 10 strokes of a homogenizer and centrifuged at 15,000 rpm for
20 min. The pellet was resuspended in buffer containing 20mM Hepes pH 7.9, 420mM NaCl,
1.5mM MgCl2, 0.2mM EDTA, 0.5mM DTT, 0.5mM PMSF, and 25% glycerol, and then
homogenized with 10 strokes. The lysate was incubated on ice for 30min and centrifuged for
10 min at 15,000 rpm. The supernatant was saved and analyzed as the nuclear fraction. To pre-
pare the cytosolic fraction, LNCaP cells treated with LY294002 were lysed in digitonin lysis
buffer (1% digitonin, 150mM NaCl, 50mM Tris-HCl pH 7.5, 10mM MgCl2). The lysates were
centrifuged at 13,000 rpm for 10 min, and supernatants were saved as cytosolic components.
The pellets representing cytoskeletal and nuclear components were lysed in RIPA buffer.
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Plasmid construction
The pPSA7kb-luc plasmid was obtained from Dr. Jan Trapman [58,59]. A CMV-driven β-
galactosidase (β-gal) reporter was generated by cloning the lacZ gene into the pcDNA3 vector
[32,60]. Double-stranded oligonucleotides corresponding to the CDH1 sequences 5’-GGCAC
AGATGGTGTGATTACAGA-3’, 5’-GGCTGGACCGAGAGAGTTTCCCA-3’and 5’-GGCGA
GTGCCCAACTGGACCAA-‘3 were synthesized and cloned into the pLenti-shRNA vectors,
for making the E-cadherin shRNA1 shRNA2 and shRNA3 constructs respectively [52,53].
Transfection, luciferase and β-gal assays
Transient transfections were carried out using LipofectAMINE 2000 (Invitrogen). For andro-
gen induction experiments, cells were grown in T-medium or RPMI with charcoal-stripped
fetal calf serum (HyClone) for 16 to 24 hr in the presence or absence of 1 nM DHT. After an
18–24 hr incubation, cells were harvested, and the luciferase and β-gal activities were mea-
sured. The RLU from individual transfections was normalized using β-gal activity in the same
samples. Individual transfection experiments were done in triplicate and the results are
reported as mean RLU/β-gal (±SD).
Cell proliferation and colony formation
Approximately 2000 cells per well were plated and cultured as described previously [32]. Pro-
liferation assays were carried out using the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) tetrazolium kit (Promega, Madison, WI).
Cell numbers were determined by absorbance at 490 nm as suggested by the manufacturer.
For colony formation assay, LNCaP cells were plated in 6-well plates, approximately 500 cells/
well for 24 hr, and then cultured for 10–12 days. The size and number of colonies were deter-
mined by staining with crystal violet (Sigma, St. Louis, MO).
SDS-PAGE and immunoblotting
Protein fractions for immunoblotting were boiled in SDS-sample buffer and then resolved on
a 10% SDS-PAGE. The proteins were transferred onto a nitrocellulose membrane and probed
with appropriate antibodies, including anti-E-cadherin (mouse, 1:2500, #610181, BD Trans-
duction Laboratories), anti-β-Tubulin (mouse, 1:2000, #581P1702F, NeoMarkers). Proteins
were detected using the ECL kit (Amersham, Arlington Heights, IL). The nuclear fractions
were analyzed by SDS-PAGE.
RNA Isolation and Reverse Transcription-Quantitative PCR (RT-qPCR)
RNA samples were isolated from fresh mouse prostate tissues using RNeasy Mini Kit (Qiagen,
Cat #74104). Reverse transcription was performed using SuperScript IV First-Strand Synthesis
System (ThermoFisher, Cat # 18091050) and RT-qPCR assays were carried out using Power-
SYBR Green PCR Master Mix (4367659, Applied Biosystems) with specific primers (S2 Table)
on the 7500 Real-Time PCR system (Thermo Fisher Scientific).
RNA sequencing analysis
RNA sequencing analysis was performed using publically available raw sequencing data from
GEO accession number GSE115204 [33]. Using DNAnexus, raw fastq files were mapped using
STAR Mapping (1.3.3). The data was then mapped to the (GRCm38) mm10 reference genome
using BowTie2 FASTQ Read Mapper (1.4.1). Genome resource archive was built using the
Tuxedo Protocol Resource Builder (1.1.4). Gene expression results were then prepared using
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Cuffdiff (1.0.6). Differential gene expression was evaluated using edgeR via web app (https://
luyangcoh.shinyapps.io/RNAseq_Diff_analysis/) kindly provided by Lu Yang in Beckman
Research Institute at City of Hope. The database for annotation, visualization, and integrated
discovery software (DAVID v6.8) was used along with Gene Set Enrichment Analysis (GSEA
3.0) in order to identify processes that were up or down regulated in Cdh1 floxed mice com-
pared to wild-type mice based on differential gene expression. All presented processes were
identified to be statistically significant with a P-value less than 0.05.
Statistical analyses
Statistical analyses were performed using 2-tailed Student’s t test. The date was presented as
the means ± S.D and cell numbers were made comparisons between groups, using a Student’s
t test. p< 0.05 were considered significant.
Supporting information
S1 Fig. Generating R26mTmG/+:Cdh1L/L:PB-Cre4 mice. A scheme demonstrates co-occurring
recombination of the Cdh1 allele and the R26mTmG reporter allele driven by PB-Cre4 expres-
sion.
(PDF)
S2 Fig. Molecular basis for promotional role of E-cadherin knockout in Pten deficient
mouse prostate tissue. A1-B4. Representative images of H&E and IHC staining of myeloid
derived suppressor cells (MDSCs) in prostate tissue sections from Cdh1L/L:P10L/L:PB-Cre4 and
P10L/L:PB-Cre4 mice. C. RT-qPCR results comparing expression levels of the indicated genes
between Cdh1L/L:PB-Cre4, P10L/L:PB-Cre4 and Cdh1L/L:P10L/L:PB-Cre4 mice. D1-G5. Repre-
sentative images of H&E staining and IHC staining of PI3k-Akt pathway genes in the indicated
genotypes. H. RT-qPCR results comparing the expression levels of apoptosis related gene, Bcl-
2, between Cdh1L/L:PB-Cre4, P10L/L:PB-Cre4 and Cdh1L/L:P10L/L:PB-Cre4 mice. Scale bars,
located in the bottom left corner of images, are sized as indicated.
(PDF)
S1 Table. Antibodies used for IHC and IF staining (see the “Material and Methods” section
also).
(PDF)
S2 Table. Primers used for RT-qPCR for S2 Fig (see the “Material and Methods” section
also).
(PDF)
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